Silver has been in use since time immemorial in the form of metallic silver, silver nitrate, silver sulfadiazine for the treatment of burns, wounds and several bacterial infections. Silver has long been known to show a strong antimicrobial effect to microorganisms. The antimicrobial effect of 30 and 100 ppm silver nanoparticles were investigated against Escherichia coli, Staphylococcus aureus, Salmonella typhimurium, Enterococcus faecalis, Bacillus cereus, Bacillus subtilis, Paenibacillus larvae, Candida albicans and Aspergillus niger. The microorganisms were diluted with sterile distilled water and prepared dilutions of 10 6 of test microorganisms. Dilutions of microorganisms cultured to blood agar base and incubated at 37°C for 24 hours. One mL dilution of 10 6 of all of microorganisms was centrifuged at 3500 rpm for 20 minutes then 30 and 100 ppm of silver nanoparticle solutions were added. Samples were inoculated in blood agar for different time intervals i.e., 0, 2, 5, 10, 30, 60 minutes and 24 hour. Antibacterial activity of silver nanoparticles against various microorganisms was detected at 0, 2, 5, 10, 30, 60 minutes and 24 hours. As results, yeast, fungi and bacteria were inhibited at 30 and 100 ppm. But, P. larvae were not inhibited, while B. subtilis also could not be inhibited at 30 ppm. The antibacterial activity of 100 ppm was stronger than the antibacterial activity of 30 ppm of nanoparticles. Nanosilver is very effective to important pathogens.
INTRODUCTION
Silver is used in medical and surgical equipment such as endotracheal tubes, surgical meshes, catheters, dental filling materials, bandages, medical dressings and a topical cream to prevent burn-associated infections (Silver, 2003) . Silver has long been known to show a strong antimicrobial effect to microorganisms (Liau et al., 1997) . The nanosilver is effective against bacteria resistant to antibiotics, fungi and virus (Feng et al., 2000; Radzig et al., 2013) . Silver nanoparticles are reported to be effective against fungi and bacteria as well as multidrug-resistant bacteria i.e., Escherichia coli (E. coli), Staphylococcus aureus (S. aureus), Pseudomonas aeruginosa (P. aeruginosa), Proteus vulgaris (P. vulgaris), Bacillus subtilis (B. subtilis), Aspergillus niger (A. niger), Candida albicans (C. albicans), Penicillium citrinum (Pen. citrinum) (Kim et al., 2007; Marambio-Jones and Hoek 2010; Lalueza et al., 2011) .
Silver nanoparticles show great antibacterial effectiveness on important foodborne pathogens (include: Escherichia coli O157:H7, Listeria monocytogenes, Salmonella typhimurium and Vibrio parahaemolyticus) (Zhang et al., 2016) . Also, nanosilver has antifungal effect on Candida albicans, Candida glabrata, Candida crusei, Candida parapsilosis and Trichophyton mentagrophytes (Kim et al., 2008) . Silver nanoparticles have antiviral effect on human immunodeficiency virus-I and herpes simplex (Barm-pinto et al., 2009) .
Silver has been used as in creams, wound dressing, different medical devices, food containers, and water disinfection for antimicrobial agent. The new strains of bacteria were resistant to antibiotics. Therefore, new bactericides were development. The nanosilver is very effective for multidrug-resistant bacteria (Morones et al., 2005) .
Silver in ionized form or in nanoparticles have got excellent antimicrobial, antifungal activities and was used for coating medical devices for preventing biofilm
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formation by pathogenic bacteria, water purification, (Bandyopadhyay et al., 2008; Chang et al., 2008; ElNaggar et al., 2016) and wound dressing for the promotion of healing (Feng et al., 2000; Abboud et al., 2014) .
In this study, antimicrobial effect of 30 and 100 ppm silver nanoparticles were determined against E. coli, S. aureus, S. typhimurium, Ent. faecalis, B. cereus, B. subtilis, P. larvae, C. albicans, A. niger . We detected antibacterial effect of nanosilver on P. Larvae, which causes American foulbrood for honeybees the first time. We compared the efficacy of 30 and 100 ppm concentrations of silver. for 24 hours and A. niger at 37°C for 7 days. The cells were washed twice and centrifuged at 3500 rpm for 20 minutes then suspended in distilled water, obtaining a final concentration of 10 6 cells/100 ml (Sondi and Salopek-Sondi, 2004) . Each culture was divided into two replicates. The cultures were then supplemented with 100 µl of 30 ppm and 100 ppm nanosilver solutions, respectively. Samples with different concentration of nanosilver were inoculated on blood agar at the exposure time of 0, 2, 5, 10, 30, 60 minutes and 24 hours. The cultures were incubated at 37°C for 24 hours. The number of bacteria was determined by counting the colonies.
MATERIALS AND METHODS

Escherichia coli (ATCC
Antifungal effect of nanosilver for A. niger was determined according to The National Committee for Clinical Laboratory Standards (NCCLS) M29 method. A. niger was incubated Potato dextose agar at 37°C for 7 days. After, A. niger was inoculated to 1 ml of 0.85% sterile saline and, added 0.01 ml of Tween 20. Suspension of A. niger was homogenized with vortex for 15 seconds Spacciapoli et al. (2001) . 1 ml dilution of 10 6 of A. niger was centrifuged at 3500 rpm for 20 minutes. A 100 µl of 30 and 100 ppm silver solutions were added to two different cultures. Samples with nanosilver were inoculated on Potato Dextrose Agar (Bragg and Rannie, 1974) at 2, 5, 10, 30, and 60 minutes. The cultures were incubated at 37°C for 7 days. Plates without silver nanoparticles were used as negative control. We counted microorganisms growing on plates as colonies following Ki-Young et al. (2007) and Samarajeewa et al. (2017) .
RESULTS AND DISCUSSION
Thirty ppm of nanosilver solution inhibited the growth of S. typhimurium in 2 minutes. E. coli, S. aureus, A. niger, C. albicans, Ent. faecalis and B. cereus were inhibited on different time intervals of the exposure. But S. aureus was not inhibited in 24 hours time interval of exposure. P. larvae were not inhibited even in 60 min and 24 hours exposure. Bacillus subtilis was not inhibited by 30 ppm of nanosilver solution. Micro-organisms and inhibition periods are shown in Table 1 .
Ent. faecalis, S. typhimurium, B. cereus and, C. albicans were inhibited by 100 ppm of nanosilver within 2 minutes. E. coli did not grow at 10 minutes. S. aureus were inhibited at 5 minutes. A. niger and B. subtilis were not inhibited in the first 10 minutes but lost activity completely after 30 minutes. P. larvae were inhibited in the first 30 minutes but it grown 60 minutes and 24 hours. Microorganisms and inhibition periods are shown in Table  2 .
Susceptibility to nanosilver is depended on the concentration. P. larvae inhibited in the first 30 minutes but it was not inhibited by 30 and 100 ppm of nanosilver solutions. P. larvae inhibited the first 30 minutes but after it was not inhibited by 30 and 100 ppm of nanosilver solutions. Nanosilver was not effective for P. larvae. E. faecalis, S. typhimurium, B. cereus and, C. albicans were inhibited by 100 ppm of nanosilver within 2 minutes. We did not detect growth on plates. E. coli did not grow at 10 minutes. S. aureus were inhibited at 5 minutes. A. niger and, B. subtilis were not inhibited in first 10 minutes but it lost activity completely after 30 minutes.
The antibacterial activity of 100 ppm of nanoparticles was stronger than the antibacterial activity of 30 ppm of nanoparticles. But P. larvae were not inhibited after 60 minutes and 24 hours by both nanoparticle solutions. B. subtilis was not inhibited by 30 ppm nanosilver. S. aureus was inhibited at 5, 10, 30, 60 minutes but it was grown in 24 hours.
In one study, different concentrations of silver on E. coli were investigated in vitro. According to the research, it was determined that nano silver at 10 μg/cm 3 concentration was effective at 70% on 10 5 CFU of E. coli. 50-60 μg/cm 3 nanosilver concentration was effective for 100%. In the same study, 20 μg/cm3 of nano silver completely inhibited 10 4 CFU of E. coli. As the number of bacteria decreased, nano silver was effective at lower concentrations (Yoon et al., 2007) . 70 μg/mL concentration of silver nanoparticles were found to be effective on B. subtilis and E. coli. B. subtilis was found to be more susceptible to silver than E. coli (Ki-Young et al., 2007) .
In another study, antimicrobial effect of a commercial nanosilver product, NanoCidR L2000, against some foodborne pathogens was evaluated. The MIC values of Ag NPs against tested pathogens were in the range of 3.12-6.25 μg/mL. While Listeria monocytogenes showed the MIC value of 6.25 μg/mL, Escherichia coli O157:H7, Salmonella typhimurium and Vibrio parahaemolyticus all showed the MIC values of 3.12 μg/mL. However, all the pathogens showed the same MBC value of 6.25 μg/mL (Zarei et al., 2014) . Sixty-five bacterial isolates were isolated from 40 diabetic patients, S. aureus (37%) and P. aeruginosa (18.5%) were the predominant isolates in the ulcer samples. Squilla chitosan silver nanoparticles (Sq. Cs-Ag(0)) showed the maximum activity against the resistant bacteria (El- Naggar et al., 2016) .
Thirty ppm of nanosilver solution inhibited Salmonella typhimurium in 2 minutes. These results are similar to our research findings.
Conclusions:
The antibacterial activity of 100 ppm of nanoparticles was stronger than the antibacterial activity of 30 ppm of nanoparticles. Nanosilver is very effective to important pathogens. Antimicrobial activity of nanosilver can be used for pathogens.
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